Rathbones Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,680
Closed -$308K 431
2021
Q4
$308K Hold
4,680
﹤0.01% 358
2021
Q3
$294K Hold
4,680
﹤0.01% 354
2021
Q2
$282K Hold
4,680
﹤0.01% 371
2021
Q1
$258K Hold
4,680
﹤0.01% 356
2020
Q4
$255K Hold
4,680
﹤0.01% 343
2020
Q3
$234K Hold
4,680
﹤0.01% 336
2020
Q2
$207K Buy
+4,680
New +$200K ﹤0.01% 327
2020
Q1
Sell
-4,680
Closed -$206K 337
2019
Q4
$206K Sell
4,680
-35,400
-88% -$1.49M 0.01% 307
2019
Q3
$1.65M Buy
+40,080
New +$1.64M 0.05% 154

Other funds holding IHI

Rathbones Group's IHI Position: Q1 2022 in Review

Rathbones Group sold out of iShares US Medical Devices ETF (IHI) in Q1 2022, closing a stake of 4,680 shares — an estimated $308K sold.

Rathbones Group first reported a position in IHI in Q3 2019 and held it in 9 quarters. The position peaked at $1.65M in Q3 2019. 631 funds tracked by Wall St. Rank hold IHI as of Q1 2022.

  • Rathbones Group reported no remaining iShares US Medical Devices ETF position as of Q1 2022 after selling out during the quarter.
  • Rathbones Group sold 4,680 iShares US Medical Devices ETF shares in Q1 2022, an estimated $308K.
  • Rathbones Group first reported a position in iShares US Medical Devices ETF in Q3 2019 and held it in 9 quarters.
  • Rathbones Group's iShares US Medical Devices ETF position peaked at $1.65M in Q3 2019.
  • 631 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2022.

Based on Rathbones Group's 13F filing for Q1 2022, filed 11 May 2022.